Phone:| Tech Support:| E-mail:

AKTI-1/2

Product #: TL0144
Image SKU-Pack Size Stock Price($) Quantity

Documents

Details

l  General Information

Product Name

AKTI-1/2

General description

Akti-1/2 is a highly selective Akt1/Akt2 inhibitor.

Synonym

3-[1-[[4-(7-phenyl-3H-imidazo[4,5-g]quinoxalin-6-yl)phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one; Akt inhibitor VIII

Purity

≥98%(HPLC)

CAS Number

612847-09-3

Formula

C34H29N7O

Molecular Weight

551.654

Suitability

BioReagent, suitable for cell culture, etc.

l  Physical and Chemical Information

Appearance

Dark brown solid

Solubility(25)

DMSO

≥20mg/mL

Ethanol

Insoluble

Water

Insoluble

l  Biological Information

Biochem/Physiol   Actions

Isozyme selective Akt1/2 kinase inhibitor. In in vitro kinase assays, Akt1/2 kinase inhibitor shows IC50 = 58 nM, 210 nM, and 2.12 mM for Akt1, Akt2, and Akt3, respectively, The inhibition appears to be pleckstrin homology (PH) domain-dependent and the Akt1/2 kinase inhibitor has no inhibitory effect against PH domain-lacking Akts, or other closely related AGC family kinases, PKA, PKC, and SGK, even at concentrations as high as 50 μM.

Application

Akt plays a role in signal transduction pathways of cell proliferation, apoptosis, angiogenesis, and diabetes. Akt1 and Akt2 dual kinase inhibitors are capable of sensitizing tumor cells to certain apoptotic stimuli, and inhibit Akt phosphorylation in vivo. Akt1 kinase activity and its regulation by extracellular signaling factors in vivo in hematopoietic cells suggests the activation of AKT1 involves intracellular translocation of the kinase from cytosol to membrane.

l  Packaging & Storage

Packaging

5mg; 25mg; 100mg

Storage temp.

0-5

l  Precautions and Disclaimer

This   product is for R&D use only, not for drug, household, or other uses.

l  References

1.    http://www.drugbank.ca

2.    https://ncit.nci.nih.gov

3.    https://www.ncbi.nlm.nih.gov

 


天问科技